Detalhe da pesquisa
1.
Pomalidomide in heavily pretreated refractory multiple myeloma: a case report.
Future Oncol
; 13(5s): 7-9, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28116939
2.
Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study.
Cancers (Basel)
; 16(6)2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38539561
3.
Patients with early-stage myelodysplastic syndromes show increased frequency of CD4+CD25+CD127(low) regulatory T cells.
Acta Haematol
; 128(3): 178-82, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22890368
4.
Safety and Efficacy of Subcutaneous Rituximab in Previously Untreated Patients with CD20+ Diffuse Large B-Cell Lymphoma or Follicular Lymphoma: Results from an Italian Phase IIIb Study.
Adv Hematol
; 2022: 5581772, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35126524
5.
Risk of malignant lymphoma following viral hepatitis infection.
Int J Hematol
; 87(5): 474-483, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18446278
6.
Protein tyrosine phosphatase receptor type {gamma} is a functional tumor suppressor gene specifically downregulated in chronic myeloid leukemia.
Cancer Res
; 70(21): 8896-906, 2010 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20959494
7.
Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to non-Hodgkin's lymphoma.
Am J Hematol
; 76(1): 14-8, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15114591